Silo Pharma Integrates Crypto Treasury for Biopharma Growth
Silo Pharma establishes a multi-chain digital asset treasury, strategically enhancing capital for biopharmaceutical innovation and future tokenization.
GD Culture Group Acquires 7,500 Bitcoin for Treasury Expansion
This acquisition strategically fortifies GD Culture Group's digital asset reserves, optimizing its balance sheet for enhanced long-term value creation within the evolving decentralized finance landscape.
Silo Pharma Establishes Crypto Treasury with Ethereum and Solana Holdings
This strategic pivot diversifies Silo Pharma's treasury operations, leveraging decentralized assets for enhanced capital efficiency and future biopharma development.
